GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
24.60
+0.99 (4.19%)
At close: Jun 24, 2026, 4:00 PM EDT
24.88
+0.28 (1.13%)
After-hours: Jun 24, 2026, 7:13 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.69 billion as of June 24, 2026. Its market cap has increased by 98.61% in one year.
Market Cap
1.69B
Enterprise Value
1.43B
1-Year Change
98.61%
Ranking
Category
Stock Price
$24.60
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.69B, an increase of 108.80%. That is a compound annual growth rate of 15.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 1.69B | 114.25% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.55B |
| Vir Biotechnology | 1.54B |
| Ascentage Pharma Group International | 1.54B |
| Bicara Therapeutics | 1.53B |
| Novavax | 1.50B |
| SELLAS Life Sciences Group | 1.50B |
| AtaiBeckley | 1.49B |
| Ardelyx | 1.49B |